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The Aspergillus fumigatus old yellow enzyme (OYE) EasA reduces chano-
clavine-I aldehyde to dihydrochanoclavine aldehyde and works in conjunction
with festuclavine synthase at the branchpoint for ergot alkaloid pathways. The
crystal structure of the FMN-loaded EasA was determined to 1.8 Å resolution.
The active-site amino acids of OYE are conserved, supporting a similar
mechanism for reduction of the /-unsaturated aldehyde. The C-terminal tail
of one monomer packs into the active site of a monomer in the next asymmetric
unit, which is most likely to be a crystallization artifact and not a mechanism of
self-regulation.
1. Introduction
Ergot alkaloids are produced by fungi and plants and have histori-
cally been used medicinally and for psychedelic recreation (lysergic
acid derivatives), and have been the cause of poisonings with symp-
toms that were attributed to witchcraft (Schardl et al., 2006). These
secondary metabolites are derived from tryptophan and dimethylallyl
diphosphate (DMAPP) and are characterized by the tetracyclic
ergoline ring system, of which festuclavine is one of the simplest
examples, or characterized by the tricyclic ring system exemplified by
chanoclavine-I aldehyde (Fig. 1a; Schardl et al., 2006). Isotope-
feeding studies suggest that chanoclavine-I aldehyde may be a
common intermediate for the biosynthesis of all ergot alkaloids
(Floss et al., 1974). Conversion of chanoclavine-I aldehyde to dihy-
drochanoclavine aldehyde by Aspergillus fumigatus has been
reported to require an old yellow enzyme (OYE) called EasA (Cheng
et al., 2010a,b; Coyle et al., 2010; Geu-Flores et al., 2012) or FgaOx3
(Wallwey et al., 2010) for the reduction of the /-unsaturated alde-
hyde. The dihydrochanoclavine aldehyde is subsequently cyclized to
form an iminium compound. It is unknown whether the cyclization is
enzyme-catalyzed. A second reduction step to produce festuclavine
from the iminium compound is performed by the NADH-dependent
festuclavine synthase FgaFS (Wallwey et al., 2010).
The Saccharomyces pastorianus old yellow enzyme was the first
flavoenzyme to be identified (Warburg & Christian, 1932). Members
of the OYE family are found in bacteria, fungi and plants, and
catalyze the reduction of activated carbon–carbon double bonds (for
excellent reviews, see Stuermer et al., 2007; Williams & Bruce, 2002).
Here, we present the structural characterization of the A. fumigatus
OYE EasA involved in ergot alkaloid biosynthesis. These data allow
us to corroborate the proposed mechanism and to provide insight
into the oligomerization of EasA in solution and in the crystal.
2. Materials and methods
2.1. Macromolecule production
The preparation of the expression vector has been described
previously (Cheng et al., 2010a). The expression vector, which
generates C-terminally histidine-tagged EasA, was transformed into
Escherichia coli BL21(DE3) cells, which were grown in LB broth
containing 50 mg ml1 kanamycin at 37C with shaking
(175 rev min1) for 2.5 h. The temperature was reduced to 15C for
1 h until an optical density at 600 nm of 0.1 was reached. Protein
expression was induced with 50 mM IPTG and the cultures were
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incubated for 64 h. Cells were harvested by centrifugation (3800g,
4C, 10 min). The cell pellet was resuspended in 10 ml 5 mM imida-
zole, 300 mM NaCl, 20 mM Tris–HCl pH 8.0, 10% glycerol (buffer A).
The cells were disrupted using a French pressure cell (241 MPa) and
cellular debris was removed by centrifugation (20 800g, 4C, 1 h). The
lysate was applied onto 50 ml Ni–NTA resin (Qiagen) in a Kontes
column equilibrated with buffer A. The column was shaken to mix the
lysate with the resin and incubated overnight at 4C on a gently tilting
base. After 21 h, EasA was eluted from the Ni–NTA column with a
step gradient of imidazole (5, 25, 50, 100, 150 and 300 mM) in buffer
A. EasA primarily eluted at 150 mM imidazole.
To load the EasA protein with FMN (flavin mononucleotide), a
previously published procedure (Gatti et al., 1994) was modified. A
Red Sepharose (GE Healthcare) column was pre-equilibrated with
three column volumes of buffer B (50 mM potassium phosphate
monobasic pH 7.0, 10% glycerol). The 150 mM imidazole Ni–NTA
fractions (50 ml) were concentrated to 25 ml and diluted in buffer B
to a final estimated salt concentration of 25 mM NaCl. The sample
was injected and washed with eight column volumes of buffer B
followed by a linear gradient of 0–600 mM NaCl (five column
volumes) in buffer B to wash out unbound sample. The column was
washed with two column volumes of buffer B with 10 mM FMN. EasA
was eluted using a 20-column-volume linear gradient from 0 to 2 M
NaCl with 10 mM FMN in buffer B.
The fractions containing EasA from the Red Sepharose column
were pooled and applied onto a Superdex 200 size-exclusion column
(GE Healthcare) pre-equilibrated with 50 mM Tris–HCl, 150 mM
sodium citrate, 10% glycerol pH 8.0. The fractions containing EasA
were pooled, concentrated to 3 mg ml1 using an Amicon stirred cell
with a YM-30 membrane and stored at 80C. Approximately 9 mg
EasA was purified from 4 l culture. EasA eluted from the size-
exclusion column was 85% FMN-bound. The amount of FMN
loading was determined by comparing the concentration of EasA,
determined by measuring the A280 (in deionized water " =
56 840 M1 cm1), and the concentration of FMN, determined by
measuring the A446 (" = 11 500 M
1 cm1).
2.2. Crystallization
Crystals were grown at 25C using the hanging-drop vapor-diffu-
sion method with 750 ml reservoir solution consisting of 230 mM
ammonium sulfate, 100 mM MES pH 6.0, 30% PEG 8000. The
hanging drops consisted of 1.5 ml reservoir solution and 1.5 ml
24 mg ml1 protein. Yellow crystals were fully developed in 4 d with
approximate dimensions of 160  40  20 mm. For data collection,
crystals were transferred to the reservoir solution supplemented with
20% glycerol solution and were flash-cooled by plunging them into
liquid nitrogen.
2.3. Data collection and processing
X-ray diffraction data were collected on beamline 11-1 at the
Stanford Synchrotron Radiation Laboratory (SSRL), Stanford,
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Figure 1
EasA mechanism and overall structure. (a) The reaction catalyzed by the old yellow enzyme EasA from A. fumigatus, the conversion of chanoclavine-I aldehyde to
dihydrochanoclavine, is labeled in red. The next two reactions are hypothesized to be spontaneous. The final reaction for the generation of festuclavine is catalyzed by FgaFS,
festuclavine synthase. (b) EasA is a classic /-barrel, shown as a blue cartoon. The FMN (green sticks) is bound in the active-site funnel composed by eight parallel strands
of the -barrel. The backside of the barrel is closed by a two-stranded -sheet: the two strands that precede the first strand of the barrel at the N-terminus of the protein. (c)
The C-terminal tail of the red monomer packs in the active site of the blue monomer in the next asymmetric unit. The location of the active site is noted by the inclusion of
the FMN as green sticks. Protein structure pictures were generated in PyMOL (Schrödinger).
Califonia, USA using a wavelength of 0.97945 Å. Data (180) were
collected as 0.5 oscillation images (20 s exposure per frame) using
Blu-Ice (Soltis et al., 2008) with a crystal-to-detector distance of
260 mm at 173C. The crystals were assigned to space group
P212121, with unit-cell parameters a = 62.5, b = 65.9, c = 115.2 Å. The
data were indexed and scaled to 1.80 Å resolution using the XDS
program package (Kabsch, 2010).
2.4. Structure solution and refinement
Molecular-replacement calculations were performed using Phaser
(McCoy et al., 2007) with data from 38.36 to 2.5 Å resolution. A
structure of old yellow enzyme (PDB entry 1oya; Fox & Karplus,
1994) was used as a search model with FMN and waters removed,
yielding a clear solution with a log-likelihood gain of greater than 400.
The packing criterion in the automated search had to be changed to
allow a maximum number of clashes of 20 with a clash distance of 3.0
for a solution to be generated. This is not surprising in light of the
packing, which will be discussed later. The map generated with this
solution showed unmodeled electron density in the active site
corresponding to FMN and additional residues at the C-terminus.
These differences in electron density relative to the molecular-
replacement model indicate a correct solution. The FMN was built
into the density and the C-terminal tail was added followed by
iterative rounds of model building and refinement using Coot
(Emsley & Cowtan, 2004) and REFMAC5 (Murshudov et al., 2011).
Waters were added using the water-addition function in Coot, and the
suggested positions were manually verified in Coot following a
refinement cycle in REFMAC5. The model was validated using
MolProbity (Chen et al., 2010). Areas of geometric outliers are
concentrated in the loops containing residues 121–123 and residues
134–138, which had poor electron density likely owing to disorder,
including the single Ramachandran outlier, which was found at
residue 136. Data-collection and refinement statistics can be found in
Tables 1 and 2. The coordinates and structure factors have been
deposited in the Protein Data Bank with accession code 4qnw.
3. Results and discussion
3.1. Purification of EasA and loading with FMN
The preparation of EasA using a heterologous expression system
has previously been reported to typically produce enzyme that was
20–25% loaded with the FMN cofactor (Cheng et al., 2010a). In our
hands, we generally produced protein that had an even lower
percentage of FMN bound (0–6%) by a comparable purification
strategy using nickel-affinity chromatography (the protein is histi-
dine-tagged). However, a purification step was added in which Red
Sepharose is used to bind EasA (owing to its affinity for the flavin)
and the protein is eluted from the column using sodium chloride in
the presence of FMN. This is an adaptation of the protocol used to
exchange the natural flavin in p-hydroxybenzoate hydroxylase for 6-
azido FAD (Gatti et al., 1994). Finally, the protein was subjected to
size-exclusion chromatography, where it eluted as a monomer. This
complete purification procedure produced approximately 2.25 mg of
85% FMN-loaded EasA per litre of E. coli culture. The purified
protein includes a ten-amino-acid linker followed by a six-residue
histidine tag at the C-terminus.
3.2. Overall structure of EasA
The structure of EasA was determined by molecular replacement
using S. pastorianus OYE (PDB entry 1oya; Fox & Karplus, 1994),
which has 39.5% sequence identity as calculated by LALIGN (Huang
& Miller, 1991), as the search model. The final model includes a single
monomer containing residues 8–376 without chain breaks: the first
seven amino acids and the C-terminal linker and histidine tag are not
visible in the model. There is poor density for the loops containing
residues 121–123 and residues 134–138, causing poor geometric
values in these areas. A molecule of FMN is found in the active site.
There are also four sulfate ions and one glycerol molecule derived
from the mother liquor and the cryoprotectant. The model is
completed with 239 water molecules.
Not surprisingly, EasA is a strong structural homolog of OYE
(r.m.s.d. of 1.15 Å for 331 C atoms). The structure is a classic /-
barrel built up by consecutive / motifs to form a central eight-
stranded parallel -barrel surrounded by -helices (Fig. 1b). The N-
terminus forms a short antiparallel two-stranded -sheet that closes
off the back of the barrel. The FMN is bound at the other end of the
barrel, in an analogous position to the FMN in OYE. Strong density
can be seen in the simulated-annealing composite OMIT map with
the occupancy set to 1.0, suggesting that the crystallized protein is
fully loaded with FMN (Fig. 2a). The B factors for the FMN (ranging
from 13 to 24 Å2) are in good agreement with those of the
surrounding amino-acid side chains, providing quantitative evidence
for full occupancy. The FMN was initially modeled using the oxidized
configuration, but is not strictly planar in the final model; however,
the FMN is not well modeled by the butterfly bend of a reduced
flavin. It is likely that a fraction of the flavin molecules in the crystal
were reduced by the X-rays during the diffraction experiment and
this model represents the average of the oxidized and reduced states
found in the crystal.
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Table 1
Data collection and processing.
Values in parentheses are for the outer shell.




Crystal-to-detector distance (mm) 260
Rotation range per image () 0.5
Total rotation range () 180
Exposure time per image (s) 20
Space group P212121
a, b, c (Å) 62.5, 65.9, 115.2
, ,  () 90, 90, 90
Resolution range (Å) 38.41–1.80 (1.90–1.80)
Total No. of reflections 162475 (23165)
No. of unique reflections 44595 (6332)






Values in parentheses are for the outer shell.
Resolution range (Å) 35.630–1.799 (1.846–1.799)
No. of reflections 40082 (2851)
Final Rcryst 0.178 (0.221)
Final Rfree 0.221 (0.273)
Total unique observations 40082
No. of non-H atoms
Protein 2916






Overall mean B factor (Å2) 21.6
The catalytic residues found in OYE are conserved in EasA, as was
predicted from sequence alignments (Cheng et al., 2010a). A
mechanism for the reduction of chanoclavine-I aldehyde to dihy-
drochanoclavine aldehyde has been proposed (Cheng et al., 2010a)
based on the extensive literature for old yellow enzymes (Brown et
al., 1998, 2002; Fox & Karplus, 1994; Karplus et al., 1995; Kohli &
Massey, 1998; Meah et al., 2001; Williams & Bruce, 2002; Xu et al.,
1999). In this mechanism, the reductive half reaction allows reduction
of the FMN by NADPH. In the oxidative half reaction, His173 or
Asn176 hydrogen bond to the substrate aldehyde. A hydride is
transferred from the reduced FMN to the -carbon of the aldehyde,
while Tyr178 serves as a proton donor to the -carbon. The hydride
and proton transfers may be concurrent or sequential (Cheng et al.,
2010a; Kohli & Massey, 1998). The amino acids of the proposed
mechanism are indeed structurally conserved (Fig. 2b) and the
structure determined here is consistent with this mechanism.
3.3. Protein oligomerization
A monomer of one asymmetric unit packs with the C-terminus in
the active site of the monomer in the next asymmetric unit, forming a
fiber (Fig. 1c). Residues 371–376 of one monomer are adjacent to the
FMN (Fig. 2c); however, none of the residues of the linker or histi-
dine tag that follow the natural C-terminus are visible in the electron-
density maps, and would have exited the opposite side of the active-
site cleft. Many attempts were made to produce crystals with different
packing interactions and in different crystal morphologies. These
included crystallizing with NADPH, NADP+, substrate or substrate
analogs to block binding of the C-terminus in the active site. The N-
terminally His-tagged protein did not crystallize. Deletion constructs
of various lengths at the C-terminus (both in the N- and C-terminally
tagged clones) could not be overproduced in E. coli. EasA without a
histidine tag could not be overproduced.
There is evidence for self-regulation in this structural class of
enzymes by packing of a loop into the active site. The OYE homolog
12-oxophytodienoate reductase 3 (OPR3) crystallizes with loop 6
inserted into the active site of the opposing monomer, making an
inactivated homodimer (Breithaupt et al., 2006). OPR3 was likewise
shown by size-exclusion chromatography, dynamic light scattering
and analytical ultracentrifugation to exist in a monomer–dimer
equilibrium in solution and was proposed to be regulated by
homodimerization upon a phosphorylation event that was mimicked
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Figure 2
EasA active site. (a) The EasA active site is shown in stereo as a blue cartoon with the active-site residues hypothesized previously shown as light green sticks. By comparison
to OYE, these residues were proposed to be involved in FMN binding (Thr31 and Gln106), NADPH binding (His173 and Asn176) and reduction of the substrate (His173,
Asn176 and Tyr178) (Cheng et al., 2010a). The residues shown as blue sticks (Pro29, Lys225 and Arg324) hydrogen bond (dashed lines) to the FMN. The FMN is shown as
dark green sticks surrounded by a 2Fo  Fc simulated-annealing composite OMIT electron-density map (grey cages) contoured at 1.5. The composite OMIT map was
generated using PHENIX (Adams et al., 2010). (b) Overlay of EasA with old yellow enzyme with p-hydroxybenzaldehyde (HBA) bound (PDB entry 1oyb; Fox & Karplus,
1994), highlighting the location where chanoclavine-I aldehyde would bind. EasA is colored as in (a) and OYE is colored grey. (c) The extreme C-terminus of the monomer
from the adjacent unit cell, residues 3710–3760 (shown in red), packs in the active site adjacent to the FMN, blocking access of substrate or NADPH.
in the crystallization by a solvent-derived sulfate (Breithaupt et al.,
2006).
Most likely, the oligomerization observed in the EasA crystals is a
crystal-packing artifact. The amino acids that pack into the active site
are not derived from the same segment of polypeptide (an internal
loop in OPR3 versus the C-terminal tail in EasA). The C-terminal tail
of EasA is long enough to pack in the active site of the same
monomer (monomeric self-regulation), but only with a considerable
conformational change. The simplest rearrangement would orient the
C-terminus in the wrong direction relative to the observed binding. A
dimerization based on this interaction with the C-termini in the
opposing active sites would also be feasible (dimeric self-regulation):
there is sufficient length but a considerable conformational change
would be required. Self-regulation by packing of the C-terminus into
the active site (either monomeric or dimeric self-regulation) cannot
be ruled out, but there is no corroborating evidence. Size-exclusion
chromatography indicates that the protein is monomeric even at high
concentration, and previous kinetic observations showed standard
Michaelis–Menten kinetics (Cheng et al., 2010a).
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